Bruce E. Hillner
Department of Internal Medicine
Medical College of Virginia and Massey Cancer Center
Virginia Commonwealth University
Richmond 23298-0170
USA
Name/email consistency: high
- Trends in clinical trials reports in common cancers between 1989 and 2000. Hillner, B.E. J. Clin. Oncol. (2003)
- Cost-effectiveness analysis of exemestane compared with megestrol in patients with advanced breast carcinoma. Hillner, B.E., Radice, D. Cancer (2001)
- Burden of illness associated with metastatic melanoma: an audit of 100 consecutive referral center cases. Hillner, B.E., Kirkwood, J.M., Agarwala, S.S. Cancer (2001)
- Is cancer care best at high-volume providers?. Hillner, B.E. Curr. Oncol. Rep (2001)
- Pamidronate in prevention of bone complications in metastatic breast cancer: a cost-effectiveness analysis. Hillner, B.E., Weeks, J.C., Desch, C.E., Smith, T.J. J. Clin. Oncol. (2000)
- Post hoc economic analysis of temozolomide versus dacarbazine in the treatment of advanced metastatic melanoma. Hillner, B.E., Agarwala, S., Middleton, M.R. J. Clin. Oncol. (2000)
- Hospital and physician volume or specialization and outcomes in cancer treatment: importance in quality of cancer care. Hillner, B.E., Smith, T.J., Desch, C.E. J. Clin. Oncol. (2000)
- The role of bisphosphonates in metastatic breast cancer. Hillner, B.E. Semin. Radiat. Oncol (2000)
- Costs of care associated with non-small-cell lung cancer in a commercially insured cohort. Hillner, B.E., McDonald, M.K., Desch, C.E., Smith, T.J., Penberthy, L.T., Maddox, P., Retchin, S.M. J. Clin. Oncol. (1998)
